GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Group Holdings Co Ltd (TSE:4887) » Definitions » EV-to-EBITDA

Sawai Group Holdings Co (TSE:4887) EV-to-EBITDA : 8.49 (As of May. 03, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sawai Group Holdings Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sawai Group Holdings Co's enterprise value is 円320,719 Mil. Sawai Group Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円37,768 Mil. Therefore, Sawai Group Holdings Co's EV-to-EBITDA for today is 8.49.

The historical rank and industry rank for Sawai Group Holdings Co's EV-to-EBITDA or its related term are showing as below:

TSE:4887' s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.06   Med: 5.71   Max: 9.17
Current: 8.49

During the past 2 years, the highest EV-to-EBITDA of Sawai Group Holdings Co was 9.17. The lowest was -12.06. And the median was 5.71.

TSE:4887's EV-to-EBITDA is ranked better than
74.36% of 706 companies
in the Drug Manufacturers industry
Industry Median: 14.54 vs TSE:4887: 8.49

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-03), Sawai Group Holdings Co's stock price is 円5930.00. Sawai Group Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円348.860. Therefore, Sawai Group Holdings Co's PE Ratio for today is 17.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sawai Group Holdings Co EV-to-EBITDA Historical Data

The historical data trend for Sawai Group Holdings Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Group Holdings Co EV-to-EBITDA Chart

Sawai Group Holdings Co Annual Data
Trend Mar22 Mar23
EV-to-EBITDA
-11.99 6.04

Sawai Group Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -8.65 6.04 6.29 6.92 7.86

Competitive Comparison of Sawai Group Holdings Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sawai Group Holdings Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sawai Group Holdings Co's EV-to-EBITDA falls into.



Sawai Group Holdings Co EV-to-EBITDA Calculation

Sawai Group Holdings Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=320718.630/37768
=8.49

Sawai Group Holdings Co's current Enterprise Value is 円320,719 Mil.
Sawai Group Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円37,768 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sawai Group Holdings Co  (TSE:4887) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sawai Group Holdings Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5930.00/348.860
=17.00

Sawai Group Holdings Co's share price for today is 円5930.00.
Sawai Group Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円348.860.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sawai Group Holdings Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sawai Group Holdings Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Group Holdings Co (TSE:4887) Business Description

Traded in Other Exchanges
Address
5-2-30, Miyahara, Yodogawa-ku, Osaka, JPN, 532-0003
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.

Sawai Group Holdings Co (TSE:4887) Headlines

No Headlines